These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 35148580)
21. Adipose Insulin Resistance and Circulating Betatrophin Levels in Women with PCOS. He Y; Hu W; Yang G; Guo H; Liu H; Li L Biomed Res Int; 2020; 2020():1253164. PubMed ID: 32076603 [TBL] [Abstract][Full Text] [Related]
22. Assessment of circulating betatrophin concentrations in lean glucose-tolerant women with polycystic ovary syndrome. Erol O; Özel MK; Ellidağ HY; Toptaş T; Derbent AU; Yılmaz N J Obstet Gynaecol; 2017 Jul; 37(5):633-638. PubMed ID: 28319674 [TBL] [Abstract][Full Text] [Related]
23. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China. Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321 [TBL] [Abstract][Full Text] [Related]
24. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Faerch K; Vaag A; Holst JJ; Glümer C; Pedersen O; Borch-Johnsen K Diabetologia; 2008 May; 51(5):853-61. PubMed ID: 18317726 [TBL] [Abstract][Full Text] [Related]
25. Association of betatrophin with metabolic characteristics in overweight/obese and lean women with PCOS. Li L; Zhang F; Cui J; Shi Y; Xiang J; Wang X; Zhao N; Yan Q; Greenberg AS; Peng Y; Ding X Gynecol Endocrinol; 2017 Mar; 33(3):238-243. PubMed ID: 27960599 [TBL] [Abstract][Full Text] [Related]
26. Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Espes D; Lau J; Carlsson PO Diabetologia; 2014 Jan; 57(1):50-3. PubMed ID: 24078058 [TBL] [Abstract][Full Text] [Related]
27. Insulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS study. Li Y; Feng D; Esangbedo IC; Zhao Y; Han L; Zhu Y; Fu J; Li G; Wang D; Wang Y; Li M; Gao S; Willi SM BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049638 [TBL] [Abstract][Full Text] [Related]
28. Down-regulation of betatrophin enhances insulin sensitivity in type 2 diabetes mellitus through activation of the GSK-3β/PGC-1α signaling pathway. Hao Q; Zheng A; Zhang H; Cao H J Endocrinol Invest; 2021 Sep; 44(9):1857-1868. PubMed ID: 33464548 [TBL] [Abstract][Full Text] [Related]
29. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. Gómez-Ambrosi J; Pascual E; Catalán V; Rodríguez A; Ramírez B; Silva C; Gil MJ; Salvador J; Frühbeck G J Clin Endocrinol Metab; 2014 Oct; 99(10):E2004-9. PubMed ID: 25050901 [TBL] [Abstract][Full Text] [Related]
30. Serum betatrophin levels are increased and associated with insulin resistance in patients with polycystic ovary syndrome. Qu Q; Zhao D; Zhang F; Bao H; Yang Q J Int Med Res; 2017 Feb; 45(1):193-202. PubMed ID: 28222635 [TBL] [Abstract][Full Text] [Related]
31. Renal function is independently associated with circulating betatrophin. Maurer L; Schwarz F; Fischer-Rosinsky A; Schlueter N; Brachs S; Möhlig M; Pfeiffer A; Mai K; Spranger J; Bobbert T PLoS One; 2017; 12(3):e0173197. PubMed ID: 28257453 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study. Chen G; Shi L; Cai L; Lin W; Huang H; Liang J; Li L; Lin L; Tang K; Chen L; Lu J; Bi Y; Wang W; Ning G; Wen J Horm Metab Res; 2017 Feb; 49(2):135-141. PubMed ID: 27459384 [TBL] [Abstract][Full Text] [Related]
33. Circulating Levels of Betatrophin and Irisin Are Not Associated with Pancreatic β-Cell Function in Previously Diagnosed Type 2 Diabetes Mellitus Patients. Wang L; Song J; Wang C; Lin P; Liang K; Sun Y; He T; Li W; Zhao R; Qin J; Lu Y; Liu J; Liu F; Hou X; Chen L J Diabetes Res; 2016; 2016():2616539. PubMed ID: 26649318 [TBL] [Abstract][Full Text] [Related]
34. Community-based population data indicates the significant alterations of insulin resistance, chronic inflammation and urine ACR in IFG combined IGT group among prediabetic population. Lü Q; Tong N; Liu Y; Li N; Tang X; Zhao J; Cao H; Li D; Gou L; Zhang Y; Wan J; Jiang L Diabetes Res Clin Pract; 2009 Jun; 84(3):319-24. PubMed ID: 19442860 [TBL] [Abstract][Full Text] [Related]
35. Increased Cord Blood Betatrophin Levels in the Offspring of Mothers with Gestational Diabetes. Xie X; Gao H; Wu S; Zhao Y; Du C; Yuan G; Ning Q; McCormick K; Luo X PLoS One; 2016; 11(5):e0155646. PubMed ID: 27196053 [TBL] [Abstract][Full Text] [Related]
36. Circulating Betatrophin Is Strongly Increased in Pregnancy and Gestational Diabetes Mellitus. Trebotic LK; Klimek P; Thomas A; Fenzl A; Leitner K; Springer S; Kiefer FW; Kautzky-Willer A PLoS One; 2015; 10(9):e0136701. PubMed ID: 26325425 [TBL] [Abstract][Full Text] [Related]
37. Increased Serum ANGPTL8 Concentrations in Patients with Prediabetes and Type 2 Diabetes. Yin Y; Ding X; Peng L; Hou Y; Ling Y; Gu M; Wang Y; Peng Y; Sun H J Diabetes Res; 2017; 2017():8293207. PubMed ID: 29082263 [TBL] [Abstract][Full Text] [Related]
38. Circulating Betatrophin in Patients with Type 2 Diabetes: A Meta-Analysis. Li S; Liu D; Li L; Li Y; Li Q; An Z; Sun X; Tian H J Diabetes Res; 2016; 2016():6194750. PubMed ID: 26697500 [TBL] [Abstract][Full Text] [Related]
39. Association of Oxytocin with Glucose Intolerance and Inflammation Biomarkers in Metabolic Syndrome Patients with and without Prediabetes. Akour A; Kasabri V; Bulatova N; Al Muhaissen S; Naffa R; Fahmawi H; Momani M; Zayed A; Bustanji Y Rev Diabet Stud; 2018; 14(4):364-371. PubMed ID: 29590229 [TBL] [Abstract][Full Text] [Related]
40. Serum apelin and resistin levels in patients with impaired fasting glucose, impaired glucose tolerance, type 2 diabetes, and metabolic syndrome. Onalan E; Yakar B; Barım AO; Gursu MF Endokrynol Pol; 2020; 71(4):319-324. PubMed ID: 32716043 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]